Page last updated: 2024-10-25

cyclobenzaprine and Alzheimer Disease

cyclobenzaprine has been researched along with Alzheimer Disease in 1 studies

cyclobenzaprine: RN given refers to parent cpd; Lisseril is synonymous for HCl; structure
cyclobenzaprine : 5-Methylidene-5H-dibenzo[a,d]cycloheptene in which one of the hydrogens of the methylidene group is substituted by a 2-(dimethylamino)ethyl group. A centrally acting skeletal muscle relaxant, it is used as its hydrochloride salt in the symptomatic treatment of painful muscle spasm.

Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Engel, PA1
Chapron, D1

Other Studies

1 other study available for cyclobenzaprine and Alzheimer Disease

ArticleYear
Cyclobenzaprine-induced delirium in two octogenarians.
    The Journal of clinical psychiatry, 1993, Volume: 54, Issue:1

    Topics: Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Amitriptyline; Delirium; Female; Humans; Ma

1993